ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 153325 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 153325; 2) Community: the network communities that were significantly associated with the response to NSC 153325; 3) Molecule: the relationships between components within communities and NSC 153325; 4) MDR: the compounds that were significantly associated with the NSC 153325.

NSC Compound Enrichment Correlation
NSC 131233 Cyclopentanone, 2,5-bis[(dimethylamino)methyl]-, dihydrochloride 0.0119653763676521 0.43108815
NSC 173905 Pentanamide, 2-(acetylamino)-N-[3-chloro-2-oxo-1-(phenylmethyl)propyl]-4-methyl- 0.0119653763676522 0.38050405
NSC 267461 Nanaomycin 0.0119653763676522 0.54030409
NSC 621486 2-Propen-1-one, 1-(1,4-dioxo-2,6,7-trimethylquinoxalin- 3-yl)-3-(2-nitrophenyl)- 0.0119653763676522 -0.074289598
NSC 625539 Iron, trichloro[phenyl-2-pyridinylmethanone(2-pyridinyl-hydrazonato)]- 0.0119653763676522 0.3883267
NSC 625985 Null 0.0119653763676522 0.5505106
NSC 641691 Vicenistatin 0.0119653763676522 0.25558654
NSC 201459 1H-Indol-2-one, 5-bromo-2,3-dihydro-3-[[(4-methoxyphenyl) carbonyl]methylene]- 0.0131142867047947 0.53687051
NSC 248040 Null 0.0131142867047947 0.49938973
NSC 372146 1,3,5-Triazine, 2-(1-methylethenyl)-2,4-diphenoxy- 0.0131142867047947 0.4049165
Total:84  Current:21    [First] [Prev] [Next] [Last]